Trial Profile
Clinical Trials Insight: 700034416
Status:
Not stated
Phase of Trial:
Phase I
Latest Information Update: 11 Jun 2008
Price :
$35
*
At a glance
- Drugs Aflibercept (Primary) ; Fluorouracil (Primary) ; Folinic acid (Primary) ; Oxaliplatin (Primary)
- Indications Solid tumours
- Focus Adverse reactions; Therapeutic Use
- Sponsors Regeneron Pharmaceuticals; Sanofi
- 11 Jun 2008 New trial record.
- 06 Jun 2008 Preliminary results were presented at the 44th American Society of Clinical Oncology (ASCO) annual meeting.